Cargando…

Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk

Detalles Bibliográficos
Autores principales:	Ying, Wendy, Catov, Janet M., Ouyang, Pamela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201430/ https://www.ncbi.nlm.nih.gov/pubmed/30371154 http://dx.doi.org/10.1161/JAHA.118.009382

Ejemplares similares

Phenotype‐Directed Management of Hypertension in Pregnancy
por: McLaughlin, Kelsey, et al.
Publicado: (2022)

Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group
por: Gooding, Holly C., et al.
Publicado: (2020)

US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the Future
por: Kovell, Lara C., et al.
Publicado: (2015)

The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
por: Qiu, Haihua, et al.
Publicado: (2019)

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
por: Khera, Rohan, et al.
Publicado: (2020)

Contemporary Cardiovascular Imaging Methods for the Assessment of At‐Risk Myocardium
por: Wince, W. Benjamin, et al.
Publicado: (2014)

Imaging Cardiovascular Calcification
por: Wang, Ying, et al.
Publicado: (2018)

Maternal Obesity and Diabetes Mellitus as Risk Factors for Congenital Heart Disease in the Offspring
por: Helle, Emmi, et al.
Publicado: (2020)

Management of Cardiovascular Risk Factors in Adults With Congenital Heart Disease
por: Lui, George K., et al.
Publicado: (2014)

Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
por: Elgendy, Islam Y., et al.
Publicado: (2019)

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
por: Titanji, Boghuma, et al.
Publicado: (2020)

Maternal Heart Failure
por: Bright, Rachel A., et al.
Publicado: (2021)

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)

Treatment, Behavioral, and Psychosocial Components of Cardiovascular Disease Risk Among Survivors of Childhood and Young Adult Cancer
por: Berkman, Amy M., et al.
Publicado: (2015)

PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
por: Handelsman, Yehuda, et al.
Publicado: (2018)

Pulmonary Hypertension in Mitral Regurgitation
por: Patel, Harsh, et al.
Publicado: (2014)

Biomechanical and Mechanobiological Drivers of the Transition From PostCapillary Pulmonary Hypertension to Combined Pre−/PostCapillary Pulmonary Hypertension
por: Allen, Betty J., et al.
Publicado: (2023)

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
por: Feigin, Valery L., et al.
Publicado: (2020)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

American‐Style Football and Cardiovascular Health
por: Kim, Jonathan H., et al.
Publicado: (2018)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
por: Wilkinson, Michael J., et al.
Publicado: (2023)

Gene Therapy to Treat Cardiovascular Disease
por: Wolfram, Julie A., et al.
Publicado: (2013)

Role of Heme in Cardiovascular Physiology and Disease
por: Sawicki, Konrad Teodor, et al.
Publicado: (2015)

Impact of Electronic Cigarettes on the Cardiovascular System
por: Qasim, Hanan, et al.
Publicado: (2017)

The Emerging Role of Irisin in Cardiovascular Diseases
por: Fu, Jinjuan, et al.
Publicado: (2021)

Pregnancy Complicated by Valvular Heart Disease: An Update
por: Nanna, Michael, et al.
Publicado: (2014)

Role of Semaphorin Signaling During Cardiovascular Development
por: Sun, Qianchuang, et al.
Publicado: (2018)

Cardiovascular Safety Assessment in Cancer Drug Development
por: Oren, Ohad, et al.
Publicado: (2021)

Cardiovascular Diseases That Have Emerged From the Darkness
por: Maron, Barry J., et al.
Publicado: (2021)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
por: Kohli, Payal, et al.
Publicado: (2014)

Critical Limb Ischemia: Current Trends and Future Directions
por: Teraa, Martin, et al.
Publicado: (2016)

Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
por: De Luca, Leonardo, et al.
Publicado: (2021)

Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
por: Herscovici, Romana, et al.
Publicado: (2018)

Interaction Between Race, Ethnicity, Severe Mental Illness, and Cardiovascular Disease
por: O'Gallagher, Kevin, et al.
Publicado: (2022)

Examining the Paracrine Effects of Exosomes in Cardiovascular Disease and Repair
por: Gartz, Melanie, et al.
Publicado: (2018)

Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
por: Kerkelä, Risto, et al.
Publicado: (2015)

Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology
por: Belzile‐Dugas, Eve, et al.
Publicado: (2021)

Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
por: Velarde, Gladys, et al.
Publicado: (2023)

Blood Pressure Variability in Clinical Practice: Past, Present and the Future
por: Sheikh, Abu Baker, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_95criea7mt4okvrs8lmgnegb6i